Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Montoya

Showing results (211-220 of 270) with videos related to

Pageof 27
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cellsCarlos J Montoya, Hyun-Bae Jie, Lena Al-Harthi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 21, 2023
Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosisEusondia Arnett, Susanta Pahari, Chrissy M Leopold Wager, et al.
Neurologia (Barcelona, Spain)|May 31, 2011
[Patients with mild cognitive impairment and a reduced CSF Aβ₁₋₄₂ protein progress rapidly to Alzheimer's disease]J A Monge-Argilés, J Sánchez-Payá, C Muñoz-Ruiz, et al.
Journal of Biomedical Materials Research. Part A|April 25, 2013
Fabrication and in vivo thrombogenicity testing of nitric oxide generating artificial lungsKagya A Amoako, Patrick J Montoya, Terry C Major, et al.
Acta Biomaterialia|April 7, 2019
72-Hour in vivo evaluation of nitric oxide generating artificial lung gas exchange fibers in sheepAngela Lai, Caitlin T Demarest, Chi Chi Do-Nguyen, et al.
Immunology|July 31, 2007
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11Carlos J Montoya, David Pollard, Jeffrey Martinson, et al.
Antioxidants (Basel, Switzerland)|April 5, 2020
Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic StrokeEmma Martínez-Alonso, Alejandro Escobar-Peso, Maria I Ayuso, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 13, 2018
Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?M B Maldonado-Pérez, L Castro-Laria, A Caunedo-Álvarez, et al.
Briefings in Bioinformatics|August 4, 2021
Systematic evaluation of transcriptomics-based deconvolution methods and references using thousands of clinical samplesBrian B Nadel, Meritxell Oliva, Benjamin L Shou, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|February 24, 2001
[Evaluation of the tuberculin reaction in health occupation students] M P Arbeláez, M C Ocampo, J Montoya, et al.
Pageof 27

Showing results (211-220 of 270) with videos related to

Sort By:
Pageof 27
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cellsCarlos J Montoya, Hyun-Bae Jie, Lena Al-Harthi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 21, 2023
Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosisEusondia Arnett, Susanta Pahari, Chrissy M Leopold Wager, et al.
Neurologia (Barcelona, Spain)|May 31, 2011
[Patients with mild cognitive impairment and a reduced CSF Aβ₁₋₄₂ protein progress rapidly to Alzheimer's disease]J A Monge-Argilés, J Sánchez-Payá, C Muñoz-Ruiz, et al.
Journal of Biomedical Materials Research. Part A|April 25, 2013
Fabrication and in vivo thrombogenicity testing of nitric oxide generating artificial lungsKagya A Amoako, Patrick J Montoya, Terry C Major, et al.
Acta Biomaterialia|April 7, 2019
72-Hour in vivo evaluation of nitric oxide generating artificial lung gas exchange fibers in sheepAngela Lai, Caitlin T Demarest, Chi Chi Do-Nguyen, et al.
Immunology|July 31, 2007
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11Carlos J Montoya, David Pollard, Jeffrey Martinson, et al.
Antioxidants (Basel, Switzerland)|April 5, 2020
Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic StrokeEmma Martínez-Alonso, Alejandro Escobar-Peso, Maria I Ayuso, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 13, 2018
Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?M B Maldonado-Pérez, L Castro-Laria, A Caunedo-Álvarez, et al.
Briefings in Bioinformatics|August 4, 2021
Systematic evaluation of transcriptomics-based deconvolution methods and references using thousands of clinical samplesBrian B Nadel, Meritxell Oliva, Benjamin L Shou, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|February 24, 2001
[Evaluation of the tuberculin reaction in health occupation students] M P Arbeláez, M C Ocampo, J Montoya, et al.
Pageof 27